TransMedics Group Inc (TMDX) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...

The company forecasts revenue of $425 million to $445 million for the year, expecting growth of 76% to 84%. CEO Waleed Hassanein expressed confidence in the guidance, citing normalization in dynamics since October.